SSRIs Test Prep and Practice Pearls – Part 2
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist
4.9 • 773 Ratings
🗓️ 14 May 2026
⏱️ 15 minutes
🧾️ Download transcript
Summary
SSRI adverse effects are critical to know. In part 2 of this 2-part series on SSRIs, we cover the most important adverse effects to know, in addition to putting a nice bow on the most important clinical practice pearls on each SSRI. Enjoy the show!
Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!
Support The Podcast and Check Out These Amazing Resources!
Meded101 Guide to Nursing Pharmacology (Amazon Highly Rated)
Guide to Drug Food Interactions (Amazon Best Seller)
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Hey all, welcome back to the Real Life Pharmacology podcast. On this episode, I'm going to cover |
| 0:06.7 | SSRI adverse effects, as well as sum up some of the most important things you need to know |
| 0:14.3 | for practice and for your board exams and pharmacology exam. But before we get to the podcast, be sure to check out real-life pharmacology.com. |
| 0:23.9 | Get your free 31-page PDF on the top 200 drugs. |
| 0:28.3 | Great study guide, great refresher, whether you're out in practice or you're a student trying |
| 0:33.0 | to learn more about pharmacology. |
| 0:35.6 | Again, simply an email will get you access to that free 31-page |
| 0:40.3 | PDF on the top 200 drugs. All right, let's get into the podcast today. S-SRIs can cause |
| 0:46.9 | sexual dysfunction as a class-type effect. Generally, the highest risk agents here are peroxatine, probably number one. |
| 0:59.2 | Certraline also is up there a little bit. But again, all the SSRIs can contribute to that. |
| 1:06.7 | In patients that experience this adverse effects, and they're like, no way, I'm not taking another |
| 1:14.3 | SSRI. It was too problematic, too annoying, too bothersome. Usually the go-to-antidpressants to consider |
| 1:23.1 | are bupropriion and myrtazapine, which really avoid or minimize or reduce |
| 1:29.6 | the serotonergic type pathway, |
| 1:32.3 | which is theorized to contribute |
| 1:34.2 | to some of that sexual dysfunction. |
| 1:36.6 | Okay. |
| 1:37.4 | So again, sexual dysfunction, |
| 1:39.8 | definitely something you want to ask about, |
| 1:41.9 | not necessarily the most comfortable to ask about, |
| 1:44.9 | but it can be one of the more common reasons why patients discontinue their SSRI. |
| 1:53.8 | And they may not want to tell you about it as well. So really important to assess that. |
... |
Transcript will be available on the free plan in 7 days. Upgrade to see the full transcript now.
Disclaimer: The podcast and artwork embedded on this page are from Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

